Evidence mapPaperPMID 41764101Full record

ArticleMolecular neurobiology2026

Hippocampal Bioenergetics and Metabolic Profiling Identifies Fatty Acid Oxidation as a Potential Therapeutic Target in Traumatic Brain Injury.

Di Zhou, Mengxuan Shi, Mitchell D Kilgore, Yuwen Xiu, Yingjie Wang, Danni Wang, Thin Yadanar Sein, Charles Vidoudez, Amin Iskender, Gaby A Moyano and 8 more

Abstract read
In one paragraph

Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Di Zhou *Clinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0002-9248-7703
Mengxuan Shi *Clinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0009-0005-6545-1528
Mitchell D Kilgore *Clinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0003-1101-6924
Yuwen XiuClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0002-2083-7129
Yingjie WangClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0009-0000-8502-6354
Danni WangClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Thin Yadanar SeinClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Charles VidoudezHarvard Center for Mass Spectrometry, Harvard University, Cambridge, MA, 02138, USA.ORCID http://orcid.org/0000-0003-0953-7800
Amin IskenderClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Gaby A MoyanoClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Lauren M DumontClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Yinghua JiangClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0002-7344-7028
Prasad V G KatakamNeuroscience Program, Tulane Brain Institute, Tulane University, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0002-4708-9140
Bo NingCenter for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0001-9437-7244
Aaron S DumontClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0002-8077-8992
Xiaoying WangClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA.ORCID http://orcid.org/0000-0003-3636-7931
Jia FanCenter for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, 70112, USA. jfan5@tulane.edu.ORCID http://orcid.org/0000-0003-3384-0834
Ning LiuClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, 70112, USA. nliu3@tulane.edu.ORCID http://orcid.org/0000-0002-5632-0359

Funding

Tulane COBRE for Clinical and Translational Research in Cardiometabolic DiseasesP20GM109036 · TULANE UNIVERSITY OF LOUISIANA · 2025 to 2025
$2.2M
NIGMS NIH HHS P20 GM109036NIH HHS S10 OD032453
6 · The paper itself

Abstract

Traumatic brain injury (TBI) causes lasting neurological impairments, particularly learning and memory deficits associated with hippocampal damage. Emerging evidence suggests that hippocampal vulnerability may be linked to bioenergetic dysfunction, though its role remains poorly defined. A deeper understanding of post-TBI metabolic disturbances and their association with pathological outcomes could reveal novel therapeutic targets. In this study, we conducted functional bioenergetic assessments and multi-omics analyses on hippocampal slices using a mouse controlled cortical impact model of TBI. Seahorse analysis revealed a significant reduction in mitochondrial oxidative phosphorylation in dentate gyrus (DG) slices at day 1 (acute phase), which recovered by day 7 (subacute phase) post-TBI. Metabolomic profiling revealed acute impairments in purine nucleotide, glucose, amino acid, and fatty acid metabolism, most of which normalized by day 7. Isotope tracing indicated enhanced octanoate-derived fatty acid oxidation (FAO) in DG slices at day 7 post-TBI. Proteomics confirmed suppressed purine metabolism at day 1 across hippocampal subregions, while FAO remained preserved at day 1 and became significantly elevated by day 7, suggesting a compensatory metabolic adaptation. Administration of sodium octanoate, a medium-chain fatty acid, at 1 h post-TBI enhanced mitochondrial respiration at 24 h, reduced microglial counts at 48 h, and attenuated neurodegeneration by day 3. These findings identify FAO enhancement as a promising metabolic strategy to restore hippocampal bioenergetics and promote neuroprotection following TBI.

Indexed as

Brain Injuries, TraumaticEnergy MetabolismFatty AcidsHippocampusMetabolomicsAnimalsMaleMiceMice, Inbred C57BLMitochondriaOxidation-ReductionFatty AcidsBioenergetics dysfunctionFatty acid oxidationHippocampusSodium octanoateTraumatic brain injury

Identifiers

PMID41764101
PMCPMC12950101

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.